(2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide

C178H194N30O10 — CID 157110229

IUPAC(2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide
SMILESCc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3c(C)n[nH]c3C)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3ccc(=O)n(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3ccn(CC(=O)N4CCCC4)c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3c(C)n[nH]c3C)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3ccc(=O)n(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3ccn(CC(=O)N4CCCC4)c3)cn2)c2ccccc2)cc1
InChIInChI=1S/2C33H37N5O2.2C28H29N5O2.2C28H31N5O/c2*1-24-10-12-26(13-11-24)25(2)20-35-32(27-8-4-3-5-9-27)33(40)36-30-15-14-28(21-34-30)29-16-19-37(22-29)23-31(39)38-17-6-7-18-38;2*1-19-9-11-21(12-10-19)20(2)17-30-27(22-7-5-4-6-8-22)28(35)31-25-15-13-23(18-29-25)24-14-16-26(34)33(3)32-24;2*1-18-10-12-22(13-11-18)19(2)16-30-27(23-8-6-5-7-9-23)28(34)31-25-15-14-24(17-29-25)26-20(3)32-33-21(26)4/h2*3-5,8-16,19,21-22,25,32,35H,6-7,17-18,20,23H2,1-2H3,(H,34,36,40);2*4-16,18,20,27,30H,17H2,1-3H3,(H,29,31,35);2*5-15,17,19,27,30H,16H2,1-4H3,(H,32,33)(H,29,31,34)/t25-,32+;25-,32-;20-,27+;20-,27-;19-,27+;19-,27-/m111111/s1
InChIKeyAGTMKKKANOSUIK-CBCSSCOASA-N
MW2913.71 g/mol
LogP30.50
Rot. Bonds52

About (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide

(2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide (PubChem CID 157110229) has the molecular formula C178H194N30O10 and a molecular weight of 2913.71 g/mol. Its IUPAC name is (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide.

Molecular Properties

Compound Name(2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide
PubChem CID157110229
Molecular FormulaC178H194N30O10
Molecular Weight2913.71 g/mol
Exact Mass2911.56
IUPAC Name(2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide
SMILESCc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3c(C)n[nH]c3C)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3ccc(=O)n(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3ccn(CC(=O)N4CCCC4)c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3c(C)n[nH]c3C)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3ccc(=O)n(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3ccn(CC(=O)N4CCCC4)c3)cn2)c2ccccc2)cc1
InChIInChI=1S/2C33H37N5O2.2C28H29N5O2.2C28H31N5O/c2*1-24-10-12-26(13-11-24)25(2)20-35-32(27-8-4-3-5-9-27)33(40)36-30-15-14-28(21-34-30)29-16-19-37(22-29)23-31(39)38-17-6-7-18-38;2*1-19-9-11-21(12-10-19)20(2)17-30-27(22-7-5-4-6-8-22)28(35)31-25-15-13-23(18-29-25)24-14-16-26(34)33(3)32-24;2*1-18-10-12-22(13-11-18)19(2)16-30-27(23-8-6-5-7-9-23)28(34)31-25-15-14-24(17-29-25)26-20(3)32-33-21(26)4/h2*3-5,8-16,19,21-22,25,32,35H,6-7,17-18,20,23H2,1-2H3,(H,34,36,40);2*4-16,18,20,27,30H,17H2,1-3H3,(H,29,31,35);2*5-15,17,19,27,30H,16H2,1-4H3,(H,32,33)(H,29,31,34)/t25-,32+;25-,32-;20-,27+;20-,27-;19-,27+;19-,27-/m111111/s1
InChIKeyAGTMKKKANOSUIK-CBCSSCOASA-N
XLogP30.50
TPSA501.74 Ų
H-Bond Donors14
H-Bond Acceptors30
Rotatable Bonds52
Heavy Atoms218
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002913.71
LogP ≤ 530.50
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1030

Analyze (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide?
The IUPAC name of (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide (CID 157110229) is (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide.
What is the SMILES notation for (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide?
The canonical SMILES for (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide is Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3c(C)n[nH]c3C)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3ccc(=O)n(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3ccn(CC(=O)N4CCCC4)c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3c(C)n[nH]c3C)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3ccc(=O)n(C)n3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3ccn(CC(=O)N4CCCC4)c3)cn2)c2ccccc2)cc1.
What is the InChIKey of (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide?
The InChIKey is AGTMKKKANOSUIK-CBCSSCOASA-N. The full InChI is InChI=1S/2C33H37N5O2.2C28H29N5O2.2C28H31N5O/c2*1-24-10-12-26(13-11-24)25(2)20-35-32(27-8-4-3-5-9-27)33(40)36-30-15-14-28(21-34-30)29-16-19-37(22-29)23-31(39)38-17-6-7-18-38;2*1-19-9-11-21(12-10-19)20(2)17-30-27(22-7-5-4-6-8-22)28(35)31-25-15-13-23(18-29-25)24-14-16-26(34)33(3)32-24;2*1-18-10-12-22(13-11-18)19(2)16-30-27(23-8-6-5-7-9-23)28(34)31-25-15-14-24(17-29-25)26-20(3)32-33-21(26)4/h2*3-5,8-16,19,21-22,25,32,35H,6-7,17-18,20,23H2,1-2H3,(H,34,36,40);2*4-16,18,20,27,30H,17H2,1-3H3,(H,29,31,35);2*5-15,17,19,27,30H,16H2,1-4H3,(H,32,33)(H,29,31,34)/t25-,32+;25-,32-;20-,27+;20-,27-;19-,27+;19-,27-/m111111/s1.
What are the key properties of (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide?
(2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide has a molecular weight of 2913.71 g/mol, XLogP of 30.50, 52 rotatable bonds, 14 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(3,5-dimethyl-1H-pyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-N-[5-(1-methyl-6-oxopyridazin-3-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[1-(2-oxo-2-pyrrolidin-1-ylethyl)pyrrol-3-yl]-2-pyridinyl]-2-phenylacetamide is sourced from PubChem (CID 157110229), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).